Crinetics Pharmaceuticals, Inc. Deferred Tax Liabilities, Leasing Arrangements
Crinetics Pharmaceuticals, Inc. (CRNX) had Deferred Tax Liabilities, Leasing Arrangements of $11.59 million as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesLeasingArrangements · last filed 2025-02-27
- 2024-12-31: Deferred Tax Liabilities, Leasing Arrangements $11.59M.
- 2023-12-31: Deferred Tax Liabilities, Leasing Arrangements $10.89M.
- 2022-12-31: Deferred Tax Liabilities, Leasing Arrangements $648.00K.
- 2021-12-31: Deferred Tax Liabilities, Leasing Arrangements $1.13M.
| Period end | Deferred Tax Liabilities, Leasing Arrangements |
|---|---|
| 2024-12-31 | $11.59M 10-K · filed 2025-02-27 |
| 2023-12-31 | $10.89M 10-K · filed 2025-02-27 |
| 2022-12-31 | $648.00K 10-K · filed 2024-02-28 |
| 2021-12-31 | $1.13M 10-K · filed 2023-02-28 |
| 2020-12-31 | $1.36M 10-K · filed 2022-03-30 |
| 2019-12-31 | $1.56M 10-K · filed 2021-03-30 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-09 |